GeneLink's Q1 Revenues Fall 45 Percent
May 23, 2012
GeneLink's Q1 Revenues Fall 45 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- GeneLink's Sales Rise 17 Percent in Q3
November 16, 2009 / GenomeWeb Daily News - Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News - RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News - Trovagene's Q1 Revenues Rise
May 15, 2013 / GenomeWeb Daily News